| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/25/1997 | US5614395 Screening for agrochemicals having the ability to induce systemic acquired resistance in plants |
| 03/25/1997 | US5614388 PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| 03/25/1997 | US5614385 Morphogens |
| 03/25/1997 | US5614384 Hepatitis B virus surface proteins with reduced host carbohydrate content |
| 03/25/1997 | US5614382 Plasmid for production of CRM protein and diphtheria toxin |
| 03/25/1997 | US5614381 Method for the inducible production of proteins in genetically modified eukaryotic host-cells multiplied in vivo |
| 03/25/1997 | US5614379 Process for preparing anti-obesity protein |
| 03/25/1997 | US5614371 Ri fusion antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof |
| 03/25/1997 | US5614370 Assay to identify human C5a antagonists and agonists |
| 03/25/1997 | US5614369 Endotoxin binding and neutralizing protein and uses thereof |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614365 DNA polymerase having modified nucleotide binding site for DNA sequencing |
| 03/25/1997 | US5614364 Genetic marker for improved milk production traits in cattle |
| 03/25/1997 | US5614363 TSH receptor |
| 03/25/1997 | US5614195 Coccidiosis poultry vaccine |
| 03/25/1997 | US5614194 Protective peptide antigen |
| 03/25/1997 | US5614193 Hantavirus vaccine |
| 03/25/1997 | US5614192 T cell receptor peptides as therapeutics for immune-related disease |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | US5614185 Compositions containing reduced, microbially produced interleukin-2 (IL-2) |
| 03/25/1997 | US5614184 Recombinant human erythropoietin mutants and therapeutic methods employing them |
| 03/25/1997 | US5614183 Use of CSF-1 to treat bacterial infections |
| 03/25/1997 | CA2108120C Method of treating gastrointestinal ulcers with platelet derived growth factor |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof |
| 03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
| 03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/23/1997 | CA2185856A1 Peptide ligands which bind to von willebrand factor |
| 03/20/1997 | WO1997010507A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/20/1997 | WO1997010361A1 Method for modulating cell apoptosis |
| 03/20/1997 | WO1997010354A1 ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR |
| 03/20/1997 | WO1997010349A1 Materials and methods for treating neurodegenerative diseases and for screening for candidate apoptosis inhibitors and inducers |
| 03/20/1997 | WO1997010347A1 Expression cassettes and methods for delivery of animal vaccines |
| 03/20/1997 | WO1997010343A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 03/20/1997 | WO1997010342A1 Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
| 03/20/1997 | WO1997010339A1 Flowering genes |
| 03/20/1997 | WO1997010338A1 Improved interleukin-6 receptor antagonist |
| 03/20/1997 | WO1997010337A1 Steroid receptor coactivator compositions and methods of use |
| 03/20/1997 | WO1997010336A1 A kinase anchoring protein and uses thereof |
| 03/20/1997 | WO1997010335A1 Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific t-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| 03/20/1997 | WO1997010333A1 Novel proteins remarkably expressed in liver cancer, genes encoding the same, antibodies against the same, and method for detecting the expression of the same |
| 03/20/1997 | WO1997010330A1 Combined ligand and receptor display |
| 03/20/1997 | WO1997010269A1 Immunotherapeutic methods using tumor antigenic peptides coated on cells and vaccines made thereof |
| 03/20/1997 | WO1997010268A1 Spray-drying haemoglobin |
| 03/20/1997 | WO1997010267A1 HUMAN SMCY cDNA AND RELATED PRODUCTS |
| 03/20/1997 | WO1997010266A1 Non-receptor mediated imaging agents |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010260A1 Alcohol-free wet extraction of gluten dough into gliadin and glutenin |
| 03/20/1997 | WO1997010258A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | WO1997010006A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | WO1997010001A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | WO1997010000A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | WO1997009999A1 Methods and compositions for treatment of hsv-2 infections and conditions |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009994A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1997004114A3 Isolated dna sequence for use as a regulator region in a chimeric gene useful for transforming plants |
| 03/20/1997 | WO1997003187A3 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof |
| 03/20/1997 | WO1996033271A3 Genetic markers for breast and ovarian cancer |
| 03/20/1997 | WO1996025498A3 Mpl ligand analogs |
| 03/20/1997 | DE19549390A1 Compsn. contg. synthetic peptide(s) reactive with hepatitis C related antibodies |
| 03/20/1997 | DE19535853A1 Varianten des humanen rekombinanten Interferon-gamma (rhu-IFN-gamma) mit erhöhter thermischer Stabilität Variants of the human recombinant interferon-gamma (rhu-IFN-gamma) with increased thermal stability |
| 03/20/1997 | DE19534759A1 DNA coding for starch-binding protein |
| 03/20/1997 | DE19534579A1 Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln Nucleic acid molecules encoding proteins which mediate the adhesion of Neisseria cells to human cells |
| 03/20/1997 | CA2238694A1 Human smcy cdna and related products |
| 03/20/1997 | CA2232048A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | CA2232033A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 03/20/1997 | CA2232023A1 Expression cassettes and methods for delivery of animal vaccines |
| 03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231998A1 Therapeutic and prophylactic methods using heat shock proteins |
| 03/20/1997 | CA2231850A1 Steroid receptor coactivator compositions and methods of use |
| 03/20/1997 | CA2231843A1 Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom |
| 03/20/1997 | CA2231804A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/20/1997 | CA2231352A1 Non-receptor mediated imaging agents |
| 03/20/1997 | CA2230483A1 Combined ligand and receptor display |
| 03/20/1997 | CA2229408A1 Spray-drying haemoglobin |
| 03/20/1997 | CA2229307A1 Circular dna molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 03/19/1997 | EP0763598A1 Method of preparing a fusion protein |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763205A1 Nucleic acid sequences controlling lung cell-specific gene expression |
| 03/19/1997 | EP0763204A1 Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay |
| 03/19/1997 | EP0763136A1 Method and probes for detecting markers bound to the locus of child spinal muscular atrophies |
| 03/19/1997 | EP0763122A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 03/19/1997 | EP0763121A1 Method of cancer treatment by p53 protein control |
| 03/19/1997 | EP0763117A1 Synthetic leader peptide sequences |
| 03/19/1997 | EP0763114A2 Hepatitis g virus and molecular cloning thereof |
| 03/19/1997 | EP0763113A1 Genetic sequences conferring disease resistance in plants and uses therefor |
| 03/19/1997 | EP0763111A1 Epil/placentine |
| 03/19/1997 | EP0763110A2 Mn gene and protein |
| 03/19/1997 | EP0763109A1 Factor interacting with nuclear proteins |